Try Ageless Review
Best for: Cost-sensitive patients seeking the lowest-tier compounded GLP-1 prices with a LegitScript-verifiable telehealth platform, especially those who want non-injectable oral forms (drops or troche) for needle-aversion and accept the weaker oral-compounded evidence base.
Try Ageless (tryageless.com) is a longevity + metabolic health telehealth platform offering compounded semaglutide and tirzepatide in THREE form factors — injection, troche (lozenge), and drops (sublingual) — a broader form-factor range than most DTC competitors. Verbatim FDA compounded-medication disclaimer published: 'Compounded medications, including semaglutide and tirzepatide, are not FDA-approved and have not been reviewed by the FDA for safety, efficacy, or quality.' LegitScript Certified with verifiable ID 123956 (visible in footer seal). Pricing: Semaglutide injection $119 (discounted from $169), Tirzepatide injection $169 (from $219), Semaglutide drops $199 (from $249), Tirzepatide drops $249 (from $299), Semaglutide troche $249 (from $299) — among the more aggressive promotional pricing in the WLR directory. Corporate address: Suite 305, 131 Continental Dr, Newark, DE 19713 (DE-LLC pattern common for DTC telehealth). Brand positioning: 'Clinician-Guided Telehealth for Longevity & Metabolic Health' covering weight loss, energy, hormone support, and sexual wellness — broader scope than weight-loss-only competitors. Pharmacy partner NOT named (only 'state-licensed pharmacies' generic framing). Named medical director NOT disclosed. Live-verified 2026-05-19.
Medium confidence · Last verified 2026-05-19 via manual · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Try Ageless is a solid telehealth option with balanced features and pricing.
Score Breakdown
Drugs Offered
Try Ageless prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| Injection (introductory) | compounded | $119 |
| Injection (introductory) | compounded | $169 |
| Drops / sublingual (introductory) | compounded-oral | $199 |
| Drops / sublingual (introductory) | compounded-oral | $249 |
| Troche / lozenge (introductory) | compounded-oral | $249 |
✓ Pros
- •LegitScript Certified with visible ID (123956) — verifiable signal vs badge-only competitors
- •THREE compounded form factors offered: injection, troche, sublingual drops — broadest DTC form-factor range in the WLR directory
- •Verbatim FDA compounded-medication disclaimer published (uncommon transparency)
- •Among the lowest advertised introductory prices — semaglutide injection $119/mo is one of the cheapest tier-1 prices we track
- •Delaware corporate address disclosed (Suite 305, 131 Continental Dr, Newark, DE 19713)
- •Longevity + metabolic health positioning aligns with the broader DTC longevity-medicine trend
✗ Cons
- •Introductory pricing (-17% to -30% discounts) — refill/maintenance pricing not disclosed publicly; common DTC pattern is price escalation post-introductory tier
- •Pharmacy partner NOT named (only 'state-licensed pharmacies' generic framing)
- •States-served list NOT enumerated — 'Availability depends on your state' framing
- •Named medical director NOT disclosed
- •503A vs 503B compounding designation NOT specified
- •Compounded oral forms (drops, troche) have weaker evidence base vs injectable — no STEP/SURMOUNT-equivalent oral compounded RCTs
- •Corporate legal entity (LLC/Inc/PC) NOT explicitly disclosed (Newark DE address suggests DE LLC, but designation absent)
- •Broad longevity-platform scope may dilute weight-loss-specific clinical focus vs specialist competitors
Ready to start with Try Ageless?
Starting at $119/month. See current pricing and start your free consultation.
Sources & methodology
Our Try Ageless review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of May 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Alternatives to Try Ageless
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with Try Ageless?
Starting at $119/month. See current pricing and start your free consultation.